Home / Going-concern warnings / NKGen Biotech, Inc.
Filed 2026-01-20 路 Form 10-Q 路 Accession 0001845459-26-000003 nano
Price before filing: $0.06 (2026-01-16 close, split/dividend-adjusted)
Market cap at flag: $1.7M (2026-01-20) 路 Latest: $317,134 (2026-10-16)
| Window | NKGN | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | +0.0% | -1.0% | +1.0% | 2026-02-19 |
| 90 days | +0.0% | +2.7% | -2.7% | 2026-04-20 |
| 180 days | +0.0% | +7.9% | -7.9% | 2026-07-20 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"Management has prepared cash flow forecasts which indicate that based on the Company's expected operating losses and negative cash flows, there is substantial doubt about the Company's ability to continue as a going concern for 12 months from the issuance of these unaudited condensed consolidated financial statements."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-03-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.